{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:53:10Z","timestamp":1761843190289},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.atherosclerosis.2003.09.024","type":"journal-article","created":{"date-parts":[[2004,1,2]],"date-time":"2004-01-02T10:29:21Z","timestamp":1073039361000},"page":"39-45","source":"Crossref","is-referenced-by-count":34,"title":["A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease"],"prefix":"10.1016","volume":"172","author":[{"given":"Katsunori","family":"Ikewaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisayuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichiro","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Mogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seibu","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJM198911093211907","article-title":"High-density lipoprotein\u2014the clinical implications of recent studies","volume":"321","author":"Gordon","year":"1989","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-2275(20)43114-1","article-title":"The plasma lecithins:cholesterol acyltransferase reaction","volume":"9","author":"Glomset","year":"1968","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199108083250601","article-title":"A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction","volume":"325","author":"Stampfer","year":"1991","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0021-9150(92)90276-M","article-title":"A prospective study of obesity, lipids, apolipoproteins and ischemic heart disease in women","volume":"92","author":"Coleman","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB5","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0022-2275(20)31566-2","article-title":"ABCA1. The gatekeeper for eliminating excess tissue cholesterol","volume":"42","author":"Oram","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0022-2275(20)32028-9","article-title":"Apolipoprotein A-I: structure-function relationships","volume":"41","author":"Frank","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0021-9150(01)00724-9","article-title":"Apolipoprotein A-I deficiency with accumulated risk for CHD but no symptoms of CHD","volume":"162","author":"Yokota","year":"2002","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/clinchem\/32.6.957","article-title":"Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum","volume":"32","author":"Rifai","year":"1986","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI103182","article-title":"The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum","volume":"34","author":"Havel","year":"1955","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB10","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0022-2275(20)38610-7","article-title":"New substrate for determination of serum lecithin:cholesterol acyltransferase","volume":"28","author":"Manabe","year":"1987","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/clinchem\/40.1.11","article-title":"Simplified isoelectric focusing\/immunoblotting determination of apoprotein E phenotype","volume":"40","author":"Kataoka","year":"1994","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/01.ATV.18.3.389","article-title":"A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency","volume":"18","author":"Huang","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0005-2760(81)90253-8","article-title":"Characterization of human high-density lipoproteins by gradient gel electrophoresis","volume":"665","author":"Blanche","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB14","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0022-2275(20)41957-1","article-title":"Characterization of a new human apolipoprotein A-I Yame by direct sequencing of polymerase chain reaction-amplified DNA","volume":"32","author":"Takada","year":"1991","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB15","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/nar\/11.9.2827","article-title":"Gene structure of human apolipoprotein A1","volume":"11","author":"Shoulders","year":"1983","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.ATV.19.2.348","article-title":"Compound heterozygosity for an apolipoprotein A1 gene promoter mutation and a structural nonsense mutation with apolipoprotein A1 deficiency","volume":"19","author":"Matsunaga","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0005-2760(94)90073-6","article-title":"Characterization of two new human apolipoprotein A-I variants: apolipoprotein A-I Tsushima (Trp-108\u2192Arg) and A-I Hita (Ala-95\u2192Asp)","volume":"1214","author":"Araki","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB18","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1073\/pnas.88.7.2793","article-title":"Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene","volume":"88","author":"Matsunaga","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB19","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0021-9150(97)00311-0","article-title":"High density lipoproteins and reverse cholesterol transport: lessons from mutations","volume":"137","author":"von Eckardstein","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00000441-199607000-00006","article-title":"Case report: retinopathy and neuropathy associated with complete apolipoprotein A-I deficiency","volume":"312","author":"Ng","year":"1996","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00041433-199606000-00002","article-title":"Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models","volume":"7","author":"Rader","year":"1996","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-2275(20)32333-6","article-title":"Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase","volume":"42","author":"Roosbeek","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-2275(20)37433-2","article-title":"The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes","volume":"38","author":"Kuivenhoven","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB24","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/01.CIR.94.7.1622","article-title":"Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease","volume":"94","author":"Miccoli","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2003.09.024_BIB25","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1161\/01.ATV.16.12.1416","article-title":"A cysteine-containing truncated apo A-I variant associated with HDL deficiency","volume":"16","author":"Moriyama","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915003004052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915003004052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T19:37:58Z","timestamp":1623613078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915003004052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0021915003004052"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2003.09.024","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}